Agora Target Validation: PRDX1 (peroxiredoxin 1) in Alzheimer’s Disease
Study Design & Technical Specifications
Sample Size / Cohort
Documented in primary study
Subject / Study Model
CNS Experimental / Clinical Model
Analytical Modalities
Primary Abstract & Repository Description
Source: Agora (AMP-AD)Editorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Premise
Primary Premise (Agora (AMP-AD)): "This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides." Within Alzheimer's Disease (AD), this work examines Agora, AMP-AD, PRDX1, Target Discovery, Apoptosis in relation to Aβ42/40, p-tau217, p-tau181, GFAP, NfL, and APOE ε4 genotype interactions. Authored by AMP-AD Consortium, Sage Bionetworks.
2. Study Architecture & Findings
Study Architecture: Experimental / Clinical CNS Design (primary study cohort) utilizing Multi-Omics, RNA-seq, TMT Proteomics, Metabolomics. Key reported conclusion: "This protein may have a proliferative effect and p..."
3. Secondary Analysis & Reusability
Secondary Analysis Applications: (1) Cross-referencing Multi-Omics, RNA-seq, TMT Proteomics, Metabolomics variables (Agora, AMP-AD, PRDX1, Target Discovery, Apoptosis) against open repositories in Alzheimer's Disease (AD); (2) Benchmarking feature distributions and effect sizes reported in "Agora Target Validation: PRDX1 (peroxiredoxin 1) in Alzheimer’s Disease"; (3) Informing cohort stratification and endpoint selection.
4. Methodological Caveats & Governance
Methodological Note: When integrating these Multi-Omics, RNA-seq, TMT Proteomics, Metabolomics findings, account for cohort-specific inclusion criteria (primary study cohort), potential site/instrument batch effects, and repository license terms (Synapse Open Research Data).
Data Access, Reproducibility & Analysis Starter Guide
Single-Cell & Multi-Omics Matrix Standard (AnnData .h5ad / Loom)
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This molecular neuroscience resource provides high-dimensional transcriptomic, epigenomic, or proteomic expression matrices accompanied by cell-level annotations (obs), gene/protein metadata (var), and spatial or dimensionality-reduced coordinates (obsm).
Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)
Python Quickstart: Single-Cell / Multi-Omics Analysis with Scanpy
# 1. Install scverse / Scanpy analysis stack
# pip install scanpy anndata leidenalg matplotlib
import scanpy as sc
import pandas as pd
# Load AnnData (.h5ad) or expression matrix from repository download
# Source: Agora (AMP-AD) (https://agora.adknowledgeportal.org/genes/ENSG00000117450)
adata = sc.read_h5ad("./data/cns_omics_dataset.h5ad")
# Compute mitochondrial QC metrics & filter low-quality nuclei
adata.var["mt"] = adata.var_names.str.startswith("MT-")
sc.pp.calculate_qc_metrics(adata, qc_vars=["mt"], inplace=True)
adata = adata[(adata.obs.n_genes_by_counts > 300) & (adata.obs.pct_counts_mt < 5.0), :].copy()
# Normalize, log-transform, and compute UMAP manifold
sc.pp.normalize_total(adata, target_sum=1e4)
sc.pp.log1p(adata)
sc.pp.highly_variable_genes(adata, n_top_genes=2000, batch_key="donor_id")
sc.tl.pca(adata)
sc.pp.neighbors(adata)
sc.tl.umap(adata)Recommended Open-Source Software & SDKs
Scalable Python toolkit for analyzing AnnData (.h5ad) single-cell gene expression matrices.
R toolkit for single-cell and spatial transcriptomics quality control, integration, and clustering.
Quantitative proteomics software package designed for analyzing large mass-spectrometric data sets.
Standardized 4-Step Workflow & Governance Checklist
Standardized Acquisition & Preprocessing Workflow
1. Load Count Matrix & Cell Metadata (AnnData / Seurat)
Import raw UMI counts or normalized expression tables alongside donor clinical metadata (Braak stage, APOE genotype, PMI).
2. Quality Control & Doublet / Ambient RNA Filtering
Filter low-quality nuclei/cells based on mitochondrial read fraction, minimum detected genes, and Scrublet/CellBender scores.
3. Batch Integration & Cell-Type Taxonomy Mapping
Correct for donor and sequencing batch effects using Harmony or scVI, then map clusters to Allen Brain Map reference taxonomies.
4. Pseudobulk Differential Expression & Pathway Enrichment
Aggregate counts at the donor-celltype level (Pseudobulk DESeq2/edgeR) to avoid pseudoreplication inflation in disease vs. control comparisons.
Reproducibility & Governance Checklist
- Perform donor-level pseudobulk aggregation rather than treating thousands of cells from one donor as independent samples.
- Include post-mortem interval (PMI), RIN (RNA Integrity Number), age, and sex as covariates in linear mixed models.
- Comply with repository Data Use Agreements (e.g., Synapse/Agora controlled-access terms) if linking human genotypes.
Tags & Modalities
Bibliometrics, Peer-Review Status & Citation Export
Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv
1. Citation Metrics & Context Breakdown
Citation Context Breakdown
2. Peer-Review Validation & Revision History
Verified Publication / Open Dataset Record
Metadata and license integrity verified against primary repository records.
3. Standardized Academic Citation & BibTeX Export
AMP-AD Consortium & Sage Bionetworks (2026). Agora Target Validation: PRDX1 (peroxiredoxin 1) in Alzheimer’s Disease. Agora (AMP-AD). https://agora.adknowledgeportal.org/genes/ENSG00000117450
@article{consortium2026agor,
title = {Agora Target Validation: PRDX1 (peroxiredoxin 1) in Alzheimer’s Disease},
author = {AMP-AD Consortium and Sage Bionetworks},
year = {2026},
journal = {Agora (AMP-AD)},
howpublished = {\url{https://agora.adknowledgeportal.org/genes/ENSG00000117450}},
doi = {},
note = {CNS Open Data: alzheimer}
}Related Alzheimer's & Dementia Research & Datasets
Explore All DatasetsAgora Target Validation: INPP5D (inositol polyphosphate-5-phosphatase D) in Alzheimer’s Disease
This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the...
Agora Target Validation: NRN1 (neuritin 1) in Alzheimer’s Disease
This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a ...
Agora Target Validation: BIN1 (bridging integrator 1) in Alzheimer’s Disease
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, syna...
Agora Target Validation: HTRA1 (HtrA serine peptidase 1) in Alzheimer’s Disease
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of ...
Allen Brain Atlas: Multi-plane optical physiology during image change detection
Time series of behavioral variables and neural activity measured with multi-plane in vivo 2-photon imaging in mice performing a visual change detection task where mice were trained with image set A and tested with a novel image set B... Freely accessible open data product maintained by the Allen Institute for Brain Science.
Agora Target Validation: APOE (apolipoprotein E) in Alzheimer’s Disease
The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mu...
Active Clinical Trials & Pipeline in Alzheimer's & Dementia
View Clinical PipelineRelated Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.